Malaria-Infected Mice Are Cured by a Single Low Dose of a New Silylamide Trioxane Plus Mefloquine
Three thermally and hydrolytically stable silylamide trioxanes have been prepared from the natural trioxane artemisinin in only five simple chemical steps and in at least 56% overall yield. Two of these new chemical entities completely cured malariainfected mice at a single oral dose of only 8 mg/kg...
Saved in:
Main Authors: | Theresa A. Shapiro (Author), Gary H. Posner (Author), Nirbhay Kumar (Author), Bryan T. Mott (Author), Vandana Singhal (Author), Lauren E. Woodard (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2009-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Novel series of 1,2,4-trioxane derivatives as antimalarial agents
by: Mithun Rudrapal, et al.
Published: (2017) -
Mefloquine-curcumin combinations improve host mitochondrial respiration and decrease mitotoxic effects of mefloquine in Plasmodium berghei-infected mice
by: John Oludele Olanlokun, et al.
Published: (2024) -
Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
by: Jennifer Keiser, et al.
Published: (2014) -
Mefloquine--an aminoalcohol with promising antischistosomal properties in mice.
by: Jennifer Keiser, et al.
Published: (2009) -
Rationale for use mefloquine for COVID-19 treatment
by: V. A. Otdelenov, et al.
Published: (2020)